Skip to main content
NewslettersWatchlist

Knight Therapeutics Inc(GUD-T)
TSX

Today's Change
Real-Time Last Update

Stocks in play: Knight Therapeutics Inc.

Baystreet.ca - Baystreet - Tue Dec 19, 2023

Has entered into an exclusive license agreement with Supernus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, granting Knight the rights to seek regulatory approval and commercialize Qelbree® in Canada. Qelbree® is an extended-release formulation of viloxazine, a multimodal serotonergic and norepinephrine modulating agent (SNMA), a nonstimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD). Financial terms of the agreement were not disclosed. Knight Therapeutics Inc. shares T.GUD are trading unchanged at $5.15.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

investor newsletter
A change in market leadership may be imminent. Plus, an index-beating U.S. dividend portfolio strategy
Traders work on the floor at the New York Stock Exchange in New York, Wednesday, May 1, 2024. (AP Photo/Seth Wenig)
globe investor
Tensions rise in Silicon Valley over sales of startup stocks
SpaceX logo and Elon Musk silhouette are seen in this illustration taken, December 19, 2022.
inside the market
How pro money managers are balancing exposure to Canadian and U.S. stocks
Rob Carrick
market news
At the open: North American stock markets rise as rate-cut hopes linger
Traders work on the floor of the New York Stock Exchange (NYSE) on May 3.
market news
The close: Wall Street sharply higher as nonfarm payrolls report strengthens case for rate cuts in both the U.S. and Canada
A trader works inside a booth on the floor of the New York Stock Exchange on May 1.
market news
The close: Major North American indexes higher, led by Nasdaq, amid plethora of mixed earnings
Traders work on the floor at the New York Stock Exchange in New York, Wednesday, May 1.
international business
Trump awarded 36 million more Trump Media shares worth $1.8-billion after hitting price benchmarks
Former President Donald Trump speaks to reporters as he leaves the courtroom for the day at Manhattan criminal court, in New York, U.S., April 30, 2024. Seth Wenig/Pool via REUTERS
market news
The close: Stocks mixed as Fed leaves investors guessing as to when rate cuts will arrive
NEW YORK, NEW YORK - APRIL 29: Traders work on the floor of the New York Stock Exchange during morning trading on April 29, 2024 in New York City. Stocks opened high Monday morning amid a Federal Reserve rate decision and the monthly jobs report later this week. (Photo by Michael M. Santiago/Getty Images)

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).